These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction. Böhm M, Abdin A, Slawik J, Mahfoud F, Borer J, Ford I, Swedberg K, Tavazzi L, Batailler C, Komajda M. Eur J Heart Fail; 2023 Aug; 25(8):1429-1435. PubMed ID: 37092340 [Abstract] [Full Text] [Related]
4. [Efficacy and safety analysis of ivabradine hydrochloride treatment of Chinese patients with chronic heart failure: subgroup analysis of Chinese patients in the SHIFT study]. Hu DY, Huang DJ, Yuan ZY, Zhao RP, Yan XW, Wang MH, Chinese Investigators of SHIFT Study. Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar 24; 45(3):190-197. PubMed ID: 28316174 [Abstract] [Full Text] [Related]
14. Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta-analysis of randomized controlled trials. Bryan Richard S, Huang B, Liu G, Yang Y, Luo S. Clin Cardiol; 2021 Apr 24; 44(4):463-471. PubMed ID: 33638556 [Abstract] [Full Text] [Related]
15. Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study. Hidalgo FJ, Anguita M, Castillo JC, Rodríguez S, Pardo L, Durán E, Sánchez JJ, Ferreiro C, Pan M, Mesa D, Delgado M, Ruiz M. Int J Cardiol; 2016 Aug 15; 217():7-11. PubMed ID: 27167103 [Abstract] [Full Text] [Related]
16. An evaluation of the pharmacokinetics and pharmacodynamics of ivabradine for the treatment of heart failure. Rosa GM, Ferrero S, Ghione P, Valbusa A, Brunelli C. Expert Opin Drug Metab Toxicol; 2014 Feb 15; 10(2):279-91. PubMed ID: 24377458 [Abstract] [Full Text] [Related]
17. Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials. Fox K, Komajda M, Ford I, Robertson M, Böhm M, Borer JS, Steg PG, Tavazzi L, Tendera M, Ferrari R, Swedberg K. Eur Heart J; 2013 Aug 15; 34(29):2263-70. PubMed ID: 23536611 [Abstract] [Full Text] [Related]
18. The effects of ivabradine on left atrial electromechanical function in patients with systolic heart failure. Ozturk S, Öztürk S, Erdem FH, Erdem A, Ayhan S, Dönmez İ, Yazıcı M. J Interv Card Electrophysiol; 2016 Sep 15; 46(3):253-8. PubMed ID: 27039084 [Abstract] [Full Text] [Related]
20. Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure - J-SHIFT Study. Tsutsui H, Momomura SI, Yamashina A, Shimokawa H, Kihara Y, Saito Y, Hagiwara N, Ito H, Yano M, Yamamoto K, Ako J, Inomata T, Sakata Y, Tanaka T, Kawasaki Y, J-SHIFT Study Investigators. Circ J; 2019 Sep 25; 83(10):2049-2060. PubMed ID: 31391387 [Abstract] [Full Text] [Related] Page: [Next] [New Search]